Development of clinical diagnostic criteria for chronic plaque psoriasis: an international e‐Delphi study

Abstract

From Wiley via Jisc Publications RouterHistory: received 2020-11-22, rev-recd 2021-03-30, accepted 2021-03-31, pub-electronic 2021-05-31Article version: VoRPublication status: PublishedFunder: Sandoz; Id: http://dx.doi.org/10.13039/100011218Funder: Pfizer; Id: http://dx.doi.org/10.13039/100004319Funder: AlmirallFunder: Celgene; Id: http://dx.doi.org/10.13039/100006436Funder: Sun Pharmaceuticals and UCB PharmaFunder: Novartis; Id: http://dx.doi.org/10.13039/100004336Funder: BMSFunder: AbbVie; Id: http://dx.doi.org/10.13039/100006483Funder: Amgen; Id: http://dx.doi.org/10.13039/100002429Funder: Eli Lilly and Company; Id: http://dx.doi.org/10.13039/100004312Funder: LEO Pharma Research Foundation; Id: http://dx.doi.org/10.13039/50110000827